These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33886061)

  • 1. miR-145-5p targets paxillin to attenuate angiotensin II-induced pathological cardiac hypertrophy via downregulation of Rac 1, pJNK, p-c-Jun, NFATc3, ANP and by Sirt-1 upregulation.
    Lin KH; Kumar VB; Shanmugam T; Shibu MA; Chen RJ; Kuo CH; Ho TJ; Padma VV; Yeh YL; Huang CY
    Mol Cell Biochem; 2021 Sep; 476(9):3253-3260. PubMed ID: 33886061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LongShengZhi alleviated cardiac remodeling via upregulation microRNA-150-5p with matrix metalloproteinase 14 as the target.
    Gu Y; Zhang S; Chen X; Li Y; Liu Y
    J Ethnopharmacol; 2022 Jun; 291():115156. PubMed ID: 35245628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new miRNA regulator, miR-672, reduces cardiac hypertrophy by inhibiting JUN expression.
    Lu Y; Wu F
    Gene; 2018 Mar; 648():21-30. PubMed ID: 29339068
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Ming S; Shui-Yun W; Wei Q; Jian-Hui L; Ru-Tai H; Lei S; Mei J; Hui W; Ji-Zheng W
    Biosci Rep; 2018 Apr; 38(2):. PubMed ID: 29440459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of lncRNA MALAT1 Inhibits Angiotensin II-induced Hypertrophic Effects of Cardiomyocytes by Regulating SIRT4 via miR-93-5p.
    Ji H; Qu J; Peng W; Yang L
    Int Heart J; 2022; 63(3):602-611. PubMed ID: 35650160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ginkgolide B Protects Cardiomyocytes from Angiotensin II-Induced Hypertrophy via Regulation of Autophagy through SIRT1-FoxO1.
    Jiang Q; Lu M; Li J; Zhu Z
    Cardiovasc Ther; 2021; 2021():5554569. PubMed ID: 34257705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenoviral-directed expression of the type 1A angiotensin receptor promotes cardiomyocyte hypertrophy via transactivation of the epidermal growth factor receptor.
    Thomas WG; Brandenburger Y; Autelitano DJ; Pham T; Qian H; Hannan RD
    Circ Res; 2002 Feb; 90(2):135-42. PubMed ID: 11834705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-17-5p Promotes Cardiac Hypertrophy by Targeting Mfn2 to Inhibit Autophagy.
    Xu X; Su YL; Shi JY; Lu Q; Chen C
    Cardiovasc Toxicol; 2021 Sep; 21(9):759-771. PubMed ID: 34120306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocyte-specific enhancer factor 2C: a novel target gene of miR-214-3p in suppressing angiotensin II-induced cardiomyocyte hypertrophy.
    Tang CM; Liu FZ; Zhu JN; Fu YH; Lin QX; Deng CY; Hu ZQ; Yang H; Zheng XL; Cheng JD; Wu SL; Shan ZX
    Sci Rep; 2016 Oct; 6():36146. PubMed ID: 27796324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-195-5p Promotes Cardiomyocyte Hypertrophy by Targeting MFN2 and FBXW7.
    Wang L; Qin D; Shi H; Zhang Y; Li H; Han Q
    Biomed Res Int; 2019; 2019():1580982. PubMed ID: 31341888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD38 promotes angiotensin II-induced cardiac hypertrophy.
    Guan XH; Hong X; Zhao N; Liu XH; Xiao YF; Chen TT; Deng LB; Wang XL; Wang JB; Ji GJ; Fu M; Deng KY; Xin HB
    J Cell Mol Med; 2017 Aug; 21(8):1492-1502. PubMed ID: 28296029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-423-5p Inhibition Exerts Protective Effects on Angiotensin II-Induced Cardiomyocyte Hypertrophy.
    Xu M; Liu D; Gao X; Wang Z; Zhang L; Fan H
    Tohoku J Exp Med; 2023 Feb; 259(3):199-208. PubMed ID: 36517015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NFATc3-dependent expression of miR-153-3p promotes mitochondrial fragmentation in cardiac hypertrophy by impairing mitofusin-1 expression.
    Wang T; Zhai M; Xu S; Ponnusamy M; Huang Y; Liu CY; Wang M; Shan C; Shan PP; Gao XQ; Wang K; Chen XZ; Liu J; Xie JY; Zhang DY; Zhou LY; Wang K
    Theranostics; 2020; 10(2):553-566. PubMed ID: 31903137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Qiliqiangxin capsule alleviates cardiac hypertrophy and cardiac dysfunction by regulating miR-382-5p/ATF3 axis.
    Yin B; Jiang X; Chang X; Song C
    Clinics (Sao Paulo); 2024; 79():100496. PubMed ID: 39332150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Qiliqiangxin Attenuates Phenylephrine-Induced Cardiac Hypertrophy through Downregulation of MiR-199a-5p.
    Zhang H; Li S; Zhou Q; Sun Q; Shen S; Zhou Y; Bei Y; Li X
    Cell Physiol Biochem; 2016; 38(5):1743-51. PubMed ID: 27161004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [MicroRNA-23a knockdown attenuates angiotensin Ⅱ induced hypertrophy in rat H9c2 cells via activating PTEN and AMPK pathway].
    Teng W; Zheng XJ; Gong GH; He ZH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):329-335. PubMed ID: 32370485
    [No Abstract]   [Full Text] [Related]  

  • 17. miR-31-5p suppresses myocardial hypertrophy by targeting Nfatc2ip.
    Zhao L; Qian X; Ren Z; Wang A
    J Cell Mol Med; 2024 Jun; 28(12):e18413. PubMed ID: 38894694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of miR-142-3p improves mitochondrial function in cardiac hypertrophy.
    Liu BL; Cheng M; Hu S; Wang S; Wang L; Tu X; Huang CX; Jiang H; Wu G
    Biomed Pharmacother; 2018 Dec; 108():1347-1356. PubMed ID: 30372837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rutin Modulates MAPK Pathway Differently from Quercetin in Angiotensin II-Induced H9c2 Cardiomyocyte Hypertrophy.
    Siti HN; Jalil J; Asmadi AY; Kamisah Y
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34064664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-22 downregulation by atorvastatin in a mouse model of cardiac hypertrophy: a new mechanism for antihypertrophic intervention.
    Tu Y; Wan L; Bu L; Zhao D; Dong D; Huang T; Cheng Z; Shen B
    Cell Physiol Biochem; 2013; 31(6):997-1008. PubMed ID: 23860036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.